Late Inflammation Induced by Asbestiform Fibers in Mice Is Ameliorated by a Small Molecule Synthetic Lignan

Autor: Kinta M. Serve, Melpo Christofidou-Solomidou, Reagan Badger, Ralph A. Pietrofesa, Kyewon Park
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Male
T-Lymphocytes
medicine.medical_treatment
Adaptive Immunity
Pharmacology
medicine.disease_cause
Autoimmunity
Mice
Glucosides
Biology (General)
Butylene Glycols
Chemokine CCL2
Spectroscopy
B-Lymphocytes
biology
Asbestos
Amphibole

autoimmunity
General Medicine
Free radical scavenger
Computer Science Applications
Immunoglobulin Isotypes
Chemistry
Cytokine
Female
LGM2605
Antibody
medicine.symptom
QH301-705.5
Immunoglobulins
asbestiform fibers
Inflammation
Article
Catalysis
Libby amphibole
secoisolariciresinol diglucoside
Inorganic Chemistry
Immune system
medicine
Animals
Physical and Theoretical Chemistry
QD1-999
Molecular Biology
Interleukin-6
business.industry
Organic Chemistry
asbestos
Immunity
Innate

Mice
Inbred C57BL

Oxidative Stress
Immunoglobulin class switching
inflammation
biology.protein
business
Oxidative stress
Zdroj: International Journal of Molecular Sciences
Volume 22
Issue 20
International Journal of Molecular Sciences, Vol 22, Iss 10982, p 10982 (2021)
ISSN: 1422-0067
DOI: 10.3390/ijms222010982
Popis: Exposure to Libby amphibole (LA) asbestos-like fibers is associated with increased risk of asbestosis, mesothelioma, pulmonary disease, and systemic autoimmune disease. LGM2605 is a small molecule antioxidant and free radical scavenger, with anti-inflammatory effects in various disease models. The current study aimed to determine whether the protective effects of LGM2605 persist during the late inflammatory phase post-LA exposure. Male and female C57BL/6 mice were administered daily LGM2605 (100 mg/kg) via gel cups for 3 days before and 14 days after a 200 µg LA given via intraperitoneal (i.p.) injection. Control mice were given unsupplemented gel cups and an equivalent dose of i.p. saline. On day 14 post-LA treatment, peritoneal lavage was assessed for immune cell influx, cytokine concentrations, oxidative stress biomarkers, and immunoglobulins. During the late inflammatory phase post-LA exposure, we noted an alteration in trafficking of both innate and adaptive immune cells, increased pro-inflammatory cytokine concentrations, induction of immunoglobulin isotype switching, and increased oxidized guanine species. LGM2605 countered these changes similarly among male and female mice, ameliorating late inflammation and altering immune responses in late post-LA exposure. These data support possible efficacy of LGM2605 in the prolonged treatment of LA-associated disease and other inflammatory conditions.
Databáze: OpenAIRE